Functional characterization of Wilms tumor-suppressor WTX and tumor-associated mutants

被引:9
作者
Kim, M. K-H [1 ]
Min, D. J. [1 ]
Rabin, M. [1 ]
Licht, J. D. [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Robert H Lurie Comprehens Canc Ctr,Dept Med, Chicago, IL 60611 USA
关键词
WTX; WT1; microarray; tumor suppressor; G(0)/G(1) arrest; p21; BECKWITH-WIEDEMANN SYNDROME; KIDNEY DEVELOPMENT; BETA-CATENIN; BONE MASS; GENE; MUTATIONS; INDUCTION; FREQUENT; EVENT; TUMORIGENESIS;
D O I
10.1038/onc.2010.452
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The WTX, Wilms tumor-associated tumor-suppressor gene, is present on the X chromosome and a single WTX mutation may be sufficient to promote carcinogenesis. Unlike the WT1 tumor suppressor, a transcription factor, WTX lacks conserved functional protein domains. To study the function of WTX, we constructed inducible cell lines expressing WTX and tumor-associated WTX mutants. Induction of WTX inhibited cell growth and caused G(1)/G(0) arrest. In contrast, a short, tumor-associated truncation mutant of WTX358 only slightly inhibited cell growth without a significant cell-cycle arrest, although expression of a longer truncation mutant WTX565 led to the growth inhibition and cell-cycle arrest to a similar extent as wild-type WTX. Like WT1, WTX slowed growth and caused cell-cycle arrest through p21 induction. Gene expression profiling showed that these two tumor-suppressors regulated genes in similar pathways, including those implicated in control of the cellular growth, cell cycle, cell death, cancer and cardiovascular system development. When gene expression changes mediated by wild-type WTX were compared with those affected by mutant forms, WTX565 showed a 55% overlap (228 genes) in differentially regulated genes, whereas WTX358 regulated only two genes affected by wild-type WTX, implying that amino-acid residues 358-561 are critical for WTX function. Oncogene (2011) 30, 832-842; doi:10.1038/onc.2010.452; published online 18 October 2010
引用
收藏
页码:832 / 842
页数:11
相关论文
共 31 条
[1]  
BARDEESY N, 1995, CANCER RES, V55, P215
[2]   Regulation of osteoblastogenesis and bone mass by Wnt10b [J].
Bennett, CN ;
Longo, KA ;
Wright, WS ;
Suva, LJ ;
Lane, TF ;
Hankenson, KD ;
MacDougald, OA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (09) :3324-3329
[3]   Tumor suppressor WTX gene mutation is rare in acute leukemias [J].
Chung, Nak Gyun ;
Kim, Min Sung ;
Chung, Yeun Jun ;
Yoo, Nam Jin ;
Lee, Sug Hyung .
LEUKEMIA & LYMPHOMA, 2008, 49 (08) :1616-1617
[4]  
Englert C, 1997, CANCER RES, V57, P1429
[5]   AMER1 regulates the distribution of the tumor suppressor APC between microtubules and the plasma membrane [J].
Grohmann, Annette ;
Tanneberger, Kristina ;
Alzner, Astrid ;
Schneikert, Jean ;
Behrens, Jurgen .
JOURNAL OF CELL SCIENCE, 2007, 120 (21) :3738-3747
[6]  
Huff V, 1998, AM J MED GENET, V79, P260, DOI 10.1002/(SICI)1096-8628(19981002)79:4<260::AID-AJMG6>3.0.CO
[7]  
2-Q
[8]   Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis [J].
Jenkins, Zandra A. ;
van Kogelenberg, Margriet ;
Morgan, Tim ;
Jeffs, Aaron ;
Fukuzawa, Ryuji ;
Pearl, Esther ;
Thaller, Christina ;
Hing, Anne V. ;
Porteous, Mary E. ;
Garcia-Minaur, Sixto ;
Bohring, Axel ;
Lacombe, Didier ;
Stewart, Fiona ;
Fiskerstrand, Torunn ;
Bindoff, Laurence ;
Berland, Siren ;
Ades, Lesley C. ;
Tchan, Michel ;
David, Albert ;
Wilson, Louise C. ;
Hennekam, Raoul C. M. ;
Donnai, Dian ;
Mansour, Sahar ;
Cormier-Daire, Valerie ;
Robertson, Stephen P. .
NATURE GENETICS, 2009, 41 (01) :95-100
[9]   An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1 [J].
Kim, Marianne K. -H. ;
McGarry, Thomas J. ;
Broin, Pilib O. ;
Flatow, Jared M. ;
Golden, Aaron A. -J. ;
Licht, Jonathan D. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (27) :11154-11159
[10]  
Koesters R, 1999, CANCER RES, V59, P3880